Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Abstract Text:

Yutaka Kondo,Lanlan Shen,Seiji Suzuki,Tsuyoshi Kurokawa,Kazuo Masuko,Yasuhito Tanaka,Hideaki Kato,Yoshiki Mizuno,Masamichi Yokoe,Fuminaka Sugauchi,Noboru Hirashima,Etsuro Orito,Hirotaka Osada,Ryuzo Ueda,Yi Guo,Xinli Chen,Jean-Pierre J Issa,Yoshitaka Sekido,

Aim: The aim of the present study was to examine DNA methylation and histone modification changes in hepatocellular carcinomas (HCC). Methods: DNA methylation in the P16, RASSF1a, progesterone receptor (PGR) and estrogen receptor alpha (ERalpha) promoters was determined by quantitative bisulfite-pyrosequencing technique in HCC patients. Histone H3-lysine (K) 4, H3-K9 and H3-K27 modifications in all these four genes were examined by chromatin immunoprecipitation (ChIP) assay in HCC cell lines. Expression of two DNA methyltransferases (DNMT1 and DNMT3b) and three histone methyltransferases (SUV39H1, G9a and EZH2) in HCC patients was measured by real-time polymerase chain reaction. Results: Aberrant DNA methylation was detected in all the HCC. Patients with DNA methylation in the RASSF1a, PGR andERalpha promoters in cancers also had substantial DNA methylation in their non-cancerous liver tissues, whereas DNA methylation in the P16 promoter was cancer specific. Epigenetic states in HCC cell lines showed that silencing of P16 and RASSF1a depended on DNA methylation and histone H3-K9 methylation. However, silencing of the PGR and ERalpha genes was more closely related to H3-K27 methylation rather than DNA methylation. Consistent with the alteration of histone status, higher expression of G9a and EZH2 was found in HCC than in non-cancerous liver tissues (P < 0.01). Conclusion: These data suggest that multiple epigenetic silencing mechanisms are inappropriately active in HCC cells.

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Publishing Authors By Initials

Y Kondo,L Shen,S Suzuki,T Kurokawa,K Masuko,Y Tanaka,H Kato,Y Mizuno,M Yokoe,F Sugauchi,N Hirashima,E Orito,H Osada,R Ueda,Y Guo,X Chen,JP Issa,Y Sekido,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 37

Page Numbers: 974-83

Journal Abbreviation: Hepatol. Res.

ISSN: 1386-6346

DAY: 20

MONTH: 06

YEAR: 2007

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.

AFFILIATION: Division of Molecular Oncology, Aichi Cancer Center Research Institute, Aichi, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas Related Publications

• Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.
• Congenital generalized lipodystrophy-case report and observations on 11 patients in Japan.
• Editorial comment.
• Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.